KBC Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $353K | Buy |
1,462
+165
| +13% | +$39.8K | ﹤0.01% | 738 |
|
2025
Q1 | $316K | Sell |
1,297
-984
| -43% | -$240K | ﹤0.01% | 836 |
|
2024
Q4 | $749K | Sell |
2,281
-814
| -26% | -$267K | ﹤0.01% | 778 |
|
2024
Q3 | $1.04M | Buy |
3,095
+1,400
| +83% | +$469K | ﹤0.01% | 682 |
|
2024
Q2 | $463K | Sell |
1,695
-557
| -25% | -$152K | ﹤0.01% | 730 |
|
2024
Q1 | $779K | Sell |
2,252
-1,044
| -32% | -$361K | ﹤0.01% | 692 |
|
2023
Q4 | $1.06M | Sell |
3,296
-1,534
| -32% | -$495K | ﹤0.01% | 681 |
|
2023
Q3 | $1.73M | Sell |
4,830
-548
| -10% | -$196K | 0.01% | 607 |
|
2023
Q2 | $2.04M | Buy |
5,378
+1,781
| +50% | +$675K | 0.01% | 600 |
|
2023
Q1 | $1.72M | Sell |
3,597
-284
| -7% | -$136K | 0.01% | 666 |
|
2022
Q4 | $1.63M | Buy |
3,881
+2,263
| +140% | +$952K | 0.01% | 636 |
|
2022
Q3 | $675K | Buy |
1,618
+28
| +2% | +$11.7K | ﹤0.01% | 716 |
|
2022
Q2 | $787K | Buy |
1,590
+80
| +5% | +$39.6K | ﹤0.01% | 690 |
|
2022
Q1 | $850K | Sell |
1,510
-29,581
| -95% | -$16.7M | ﹤0.01% | 722 |
|
2021
Q4 | $23.5M | Sell |
31,091
-1,844
| -6% | -$1.39M | 0.08% | 242 |
|
2021
Q3 | $24.6M | Buy |
32,935
+25,351
| +334% | +$18.9M | 0.09% | 228 |
|
2021
Q2 | $4.89M | Buy |
7,584
+1,346
| +22% | +$867K | 0.01% | 625 |
|
2021
Q1 | $3.56M | Buy |
6,238
+1,558
| +33% | +$890K | 0.01% | 665 |
|
2020
Q4 | $15M | Hold |
4,680
| – | – | 0.01% | 712 |
|
2020
Q3 | $2.41M | Sell |
4,680
-68,744
| -94% | -$35.4M | 0.01% | 679 |
|
2020
Q2 | $33.2M | Buy |
73,424
+54,132
| +281% | +$24.4M | 0.11% | 185 |
|
2020
Q1 | $6.76M | Buy |
19,292
+17,723
| +1,130% | +$6.21M | 0.06% | 309 |
|
2019
Q4 | $581K | Buy |
+1,569
| New | +$581K | ﹤0.01% | 1064 |
|
2015
Q4 | – | Sell |
-2,232
| Closed | -$300K | – | 1266 |
|
2015
Q3 | $300K | Buy |
+2,232
| New | +$300K | 0.01% | 903 |
|